SEC Form 4 filed by Karti Karim

$RKLY
Semiconductors
Technology
Get the next $RKLY alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Karti Karim

(Last) (First) (Middle)
234 E COLORADO BLVD.
#600

(Street)
PASADENA CA 91101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Rockley Photonics Holdings Ltd [ RKLY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/17/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit $0.0 05/17/2022 A 65,322 (1) (1) Ordinary Share 65,322 $0 65,322 D
Explanation of Responses:
1. Subject to continued service as a director, the RSU will vest on the earlier of the one-year anniversary of the date of grant or the 2023 annual meeting of shareholders, subject to acceleration upon a change in control.
Remarks:
/s/ Tom Adams, Attorney-in-fact for Karim Karti 08/30/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $RKLY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RKLY

DatePrice TargetRatingAnalyst
8/12/2022$6.00 → $2.00Outperform → Neutral
Robert W. Baird
3/9/2022$20.00 → $10.00Outperform
Northland Capital Markets
3/9/2022$6.00 → $5.00Neutral
B of A Securities
3/9/2022$15.00 → $8.00Buy
Needham
12/22/2021$14.00 → $6.00Buy → Neutral
B of A Securities
9/17/2021$14.00Buy
B of A Securities
9/9/2021$22.00Outperform
Cowen
9/7/2021$15.00Buy
Needham
More analyst ratings

$RKLY
Press Releases

Fastest customizable press release news feed in the world

See more
  • Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023. About Rockley Photonics Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfo

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange ("NYSE") on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance wit

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

    Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth. Effective immediately, Richard A. Meier has been appointed president and chief executive officer, and will join the board of directors. Dr. Andrew Rickman has resigned as chief executive officer and will take on the role of executive chairman of Rockley. Chad Becker wi

    $RKLY
    Semiconductors
    Technology

$RKLY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$RKLY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$RKLY
SEC Filings

See more

$RKLY
Leadership Updates

Live Leadership Updates

See more
  • Rockley Photonics Appoints Healthcare Industry Veteran Richard A. "Randy" Meier President and Chief Financial Officer

    Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Names Nicolaus Henke to Board of Directors

    Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha

    $RKLY
    Semiconductors
    Technology
  • SpartanNash Announces Board Refreshment; Appoints Three New Independent Directors

    Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and

    $BALY
    $CLRM
    $HELE
    $NXGN
    Hotels/Resorts
    Consumer Discretionary
    Consumer Electronics/Appliances
    Industrials

$RKLY
Financials

Live finance-specific insights

See more
  • Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

    Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced its financial results for the third quarter ended September 30, 2022. During the quarter, the Company advanced its technology platform, Bioptx™, through several technical and clinical targets: Expanded Free-Living Human Study of Its B

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

    Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 877-407-0832 from the United States or +1 201-689-8433 internationally, referencing Rockley Photonics. A live webcast and replay of the conference call can be accessed from the investor relations page on Rockley's website at investors.rockleyphotonics.com. Follo

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Reports Second Quarter of Fiscal 2022 Financial Results

    Signs Supply Agreement and Receives First Commercial Purchase Order from Top-Tier Medtech Company for Bioptx™ Baseline Band, Targets Fourth Quarter to Begin Shipping Signs First Contract Research Organization Partnership to Develop and Evaluate Rockley's Bioptx™ Biomarker Sensing Platform for Use in Clinical Trials Bolsters Board of Directors and Establishes Scientific Advisory Board Rockley Photonics Holdings Limited (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. "I am proud of the progress we made in the second quarter. As we ramp towards commercial produc

    $RKLY
    Semiconductors
    Technology

$RKLY
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more